Skip to main content
. Author manuscript; available in PMC: 2013 Sep 26.
Published in final edited form as: Vaccine. 2011 Dec 29;30(7):1322–1329. doi: 10.1016/j.vaccine.2011.12.072

Fig. 4.

Fig. 4

Characterization of LT-specific CD4+ T cells using splenocytes stimulated with LT peptide #29. (A) Schematic regimen of vaccination schedule used for in vivo tumor protection experiments. (B) Intracellular cytokine staining using phycoerythrin (CD4 labeling) and fluorescein isothiocyanate (IFN-γ labeling) as fluorescent tracers followed by flow cytometry analysis to characterize LT-specific CD4+ T cell responses using splenocytes stimulated with candidate peptide #29.